• Text size      
  • Send this article to a friend
  • Print this article

Angel earnings warning sends share price down

SHARES in Angel Biotechnology Holdings fell more than 10% after it warned contract delays and difficult markets will impact on full-year earnings.

Custom byline text: 

The shares ended the day down 0.01p at 0.08p.

The company, which has a manufacturing facility at the Pentlands Science Park near Edinburgh, is seeing more inquiries for its services, but these have not yet turned into commercial contracts. Angel said a deal with TransGenRx, initially estimated at £800,000, to make a product related to immune system functions was still in place but the US firm was not "currently in a position to proceed".

Contextual targeting label: 
Arts and Entertainment

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.

MOST READ

SPONSORED LINKS

MOST COMMENTED